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A congenic strain of mice with amyloidogenic apolipoprotein A-II (Apoa2’) on the genetic background of the amyloidosis-resistant SAM-R/l strain 
was produced by 12 generations of backcrossing. Genome mapping using endogenous murine leukemia proviral markers was done in the congenic 
strain, termed Rl.Pl-Apoa2’. We confirmed that only a small region surrounding the apoA-II gene on chromosome 1 was transferred from the 
genome of the donor SAM-P/l strain. The level and particle size of plasma high density lipoprotein were decreased in Rl.Pl-ApoaZ’mice compared 
to those in the progenitor SAM-R/l mice. The function of apoA-II can be studied using this strain of mice. 
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1. INTRODUCTION 
Amyloidosis is characterized by extracellular deposi- 
tion of fibrillar amyloid protein. Apolipoprotein A-II 
(apoA-II) in mouse serum high-density lipoprotein 
(HDL) is a serum precursor of murine senile amyloid 
protein (AApoA-II) [1,2]. Three variants of apoA-II 
protein (A, B and C) with different amino acid substitu- 
tions at four positions had been found among inbred 
strains of mice [3]. The SAM-P/l and SJLIJ strains with 
a high incidence of senile amyloidosis have type C 
apoA-II with glutamine at position 5, whereas the 
SAM/R-l, C57BW6J and DDD strains with a low inci- 
dence of amyloidosis have type A or B apoA-II with 
proline at position 5 [4]. Examination of the type of 
apoA-II and amyloid deposition in the Fl, F2 and back- 
crossed mice between strains with ApoaT and Apoa2” 
or Apoa2b showed that acceleration of murine senile 
amyloidosis is linked to ApoaT and is transmitted in an 
autosomal recessive manner [3,5]. 
The SAM-P/l strain with ApoaT is a murine model 
of accelerated senescence [6] and has the following char- 
acteristics of lipid metabolism: (1) low levels of serum 
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apoA-II and HDL, (2) age-associated ecreases in 
serum levels of apoA-I and apoA-II, and (3) age-associ- 
ated increases in clearance rate of serum apoA-II [7,8]. 
To examine if the molecular type of apoA-II is a factor 
involved in the regulation of lipid metabolism and de- 
velopment of senile amyloidosis, we developed a con- 
genie strain, Rl*Pl-ApoaT containing amyloidogenic 
type C apoA-II gene of the SAM-P/l strain on the ge- 
netic background of the SAM-R/l strain, by 12 genera- 
tions of backcrossing. Lipoproteins in the congenic 
strain were compared to those in the progenitor strains 
and our findings are described herein. 
2. MATERIALS AND METHODS 
2.1. Production of congenic strains of mice 
The original parents, the SAM-R/l strain with type B apoA-II 
(Apoa2b) and the SAM-P/l strain with type C apoA-II (Apoa2’) were 
crossed and the Fl progeny were backcrossed to SAM-R/l. In each 
subsequent generation, progeny were selected that possessed the 
donor strain allele (Ap0a2~‘) at the differential ocus, Apoa2. After 
6 and 12 backcrosses, heterozygous siblings were interbred and prog- 
eny with the Apoa2dc genotype were selected. The genotype of ApoA- 
II was determined by polymorphism of the polymerase chain reaction 
(PCR)-amplified apoA-II gene for digestion by restriction enzyme 
Cfrl31 [3]. 
2.2. Genetic analysis of the congenic mice 
To analyze the genetic identity of congenic strains with the progen- 
itor strain, SAM-R/l, we used endogenous murine leukemia virus 
(MuLV) proviral markers which are dispersed over mouse chromo- 
somes [9]. High molecular weight DNA prepared from the livers was 
digested with P&I or EcoRI, separated by electrophoresis on 0.8% 
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Fig. 1. Determination of the genetic type of apoA-II gene in the 
congemc strains. The DNA was isolated from tails of SAM-P/l (lane 
l), Rl.Pl-Apoa2” (lane 2) SAM-R/l (lane 3) Rl.Pl-Apoa2‘#6 (lane 
4) a male (lane 5) and a female (lane 6) progeny used to produce 
Rl.Pl-ApoaT. ApoA-II PCR products digested with C’l31 were 
analyzed on a 3.5% agarose gel. The type C and type B apoA-II gene 
showed characteristic 152 and 106 bp bands, respectively. Molecular 
mass of the digested DNA is shown on the right (in bp). 
agarose gels, transferred to nylon membranes (GeneScreen Plus, NEN 
Products, Boston, MA, USA) and hybridized to “P-labeled oligonu- 
cleotide probes identifying xenotropic, polytropic and modified poly- 
tropic proviruses [991 I]. Membranes were exposed to -80°C for one 
week. 
2.3. Lipoprotezn quantitatzons 
All mice had been raised on a 12 h light/dark cycle and were fasted 
for 12-16 h prior to collection of blood samples obtained by cardiac 
puncture following ether anesthesia. The mice were fed a commercial 
chow (CE-2, Nihon CLEA, Tokyo, Japan) containing 4% fat. Plasma 
total cholesterol and triglyceride levels were determined using enzy- 
matic procedures (Cholesterol C-Test Wako and Triglyceride G-Test 
Wako, Wako Pure Chemical Industries Osaka, Japan). HDL cholest- 
erol was estimated according to a modified heparin-manganese precip- 
itation procedure (HDL cholesterol C-Test Wako). 
Non-denaturing gradient polyacrylamide gel electrophoresis was 
performed on minigels 84 mm wide x 90 mm high. Gels containing a 
4-l 5% linear polyacrylamide gradient were electrophoresed in 25 mM 
Tris, 192 mM glycine. Prior to electrophoresis. plasma samples (3 ~1) 
were stained for lipid by incubation for 3 h at room temperature with 
24~1 freshly prepared Sudan black B dye solution (5 parts 1 .O% Sudan 
Black B in ethylene glycol; 3 parts 40% sucrose). Electrophoresis was 
carried out at 30 mA for 2 h. 
3. RESULTS AND DISCUSSION 
After 6 and 12 generations of backcrossing, heterozy- 
gous male and female progeny (Apoa2b’c) were mated 
to produce congenic mice carrying type C apoA-II, ho- 
mozygously (Fig. 1). We termed the congenic strains 
produced by 6 and 12 backcrosses as Rl .Pl-Apoa2”#6 
and R 1 .Pl -ApoaT, respectively. 
After 6 and 12 backcrosses, we calculated that 3.13% 
and 0.05% of the genome of the donor strain (SAM-P/l) 
might be transferred to the genome of the inbred part- 
ner (SAM-R/l). We analyzed the genetic identity of the 
congenic strains with the progenitor SAM-R/l strain by 
genome mapping, using Southern blot hybridization 
with synthetic oligo-nucleotide probes specific to three 
classes of endogenous MuLV proviruses (Fig. 2). Since 
the classes of MuLV proviruses are reasonably stable 
and many copies are usually found in inbred mouse 
strains, they can serve as genetic markers when attempt- 
ing to map genetic determinants for pathologic pheno- 
types [9-121. A pair of Southern blots of DNA isolated 
from SAM-P/l and SAM-R/l mice (digested with either 
PvuII or EcoRI) were carefully compared with the data 
of Frankel et al. [9-l l] for fragment size for each class 
of MuLV proviruses. The 34 identifiable fragments 
were assigned locus numbers according to Frankel et al. 
and the 4 fragments not found in their table were given 
arbitrary alphabetical etters. The 15 fragments which 
were specific to either strain, Xenotropic (Xmv)-21 on 
chromosome 1, Xmv-h on unassigned locus, Xmv-27 on 
chromosome 13, Xmv- 15 on chromosome 9, Xmv-26 on 
chromosome 8, Xmv-24 on chromosome 6, modified 
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Fig. 2. A comparison of: A, xenotropic (Xmv); B, modified polytropic 
(Mpmv); and C, polytropic (Pmv) provirus contents of SAM-P/l (lane 
A). Rl.Pl-Apoa2’ (lane B), SAM-R/l (lane C) and Rl.Pl-ApoaZ’#6 
(lane D). Also shown are location of fragments corresponding to Xmv. 
Mpmv and Pmv loci numbered as described by Frankel et al. [9]. 
Fragments represented by alphabetical letters could not be found in 
common mouse strains defined by Frankel et al. Fragments present 
only in either progenitor SAM-P/l and SAM-R/l strain are repre- 
sented by asterisks. Xmv loci that hybridized poorly to the probe are 
represented by circles. HzndIII-digested DNA molecular size stan- 
dards are shown. 
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polytropic (Mpmv)-17 on chromosome 16, Mpmv-18 
on chromosome 11, Mpmv-19 on chromosome 4, 
Mpmv-29 on chromosome 1, polytropic (Pmv)-25 on 
chromosome 4, Pmv-35 on chromosome 16, Pmv-14 on 
chromosome 16, Pmv-32 on unassigned locus and Pmv- 
20 on chromosome 18 are represented by asterisks in 
Fig. 2. Comparison of profiles of provirus fragments of 
the congenic strains with those of their progenitor 
strains showed that almost all fragments were identical 
with those of the SAM-R/l strain, except for one frag- 
ment (Mpmv-29) in R 1 *Pl -ApoaT and three fragments 
(Mpmv-29, Xmv-15 and Xmv-21) in Rl.Pl-Apoa2’#6. 
Mpmv-29 are closely linked with the apoA-II gene on 
chromosome 1 and may be transferred from the SAM- 
P/l genome to the SAM-R/l genome together with the 
apoA-II gene. The presence of Xmv-15 on chromosome 
9 and Xmv-21 located 15 CM proximal to the centrom- 
ere from apoA-II gene in Rl.Pl-Apoa2”#6 revelaed that 
6 backcrosses were not sufficient and parts of the SAM- 
P/l genome remained in RlePl-Apoa2”#6. 
Plasma levels of total and HDL cholesterol in R 1 *Pl- 
ApoaT and Rl.Pl-ApoaT#B were significantly lower 
than those of progenitor SAM-R/l which has type B 
apoA-II (Student’s t-test P < 0.001) (Table I). Values of 
the congenic strains were much the same as values in the 
donor strain (SAM-P/l). Heterozygous Fl hybrid mice 
produced by crossing between SAM-R/l and Rl .Pl- 
ApoaT (R 1 .Pl -Apoa2b’c) revealed intermediate values 
of total and HDL cholesterol evels. There was no dif- 
ference in plasma levels of triglycerides among the 
strains and no significant differences in the levels of 
hepatic apoA-II mRNA were observed among the 
strains (K. Kitagawa et al., unpublished data). 
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Non-denaturing polyacrylamide gradient gel electro- 
phoresis was used to determine size distribution on 
HDL stained with Sudan black B (Fig. 3). A clear shift 
in the distribution of HDL particle was observed with 
HDL from the SAM-R/l strain (larger HDL), as com- 
pared to the SAM-P/l strain (smaller HDL). The con- 
genie strains resembled the donor SAM-P/l strain in 
terms of HDL size (smaller). Heterozygous Fl hybrid 
mice and HDL of an intermediate size of the progenitor 
HDL 
w 
Fig. 3. Plasma HDL from strains SAM-R/l (lanes 1,2), SAM-P/l 
(lanes 3,4), Rl.Pl-ApoaT (lanes 5,6), Rl.Pl-Apoa2W6 (lanes 7,8), 
Rl.Pl-Apoa2” (lane 9,lO) was stained with Sudan black B and sub- 
jected to non-denaturing polyacrylamide gradient (415%) gel electro- 
phoresis. 
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Table I 
Plasma lipid levels in congenic and progenitor strains 
February 1993 
Strains Type of 
apoA-II 
n Total cholesterol HDL cholesterol Triglycerides 
(mgldl) (mgldl) (mgldl) 
SAM-P/l C 5 79.91 + 11.09 51.86 + 1.69 142.22 + 47.80 
SAM-R/I B 5 135.34 + 12.05 84.30 + 6.29 134.78 + 36.52 
Rl.Pl-ApoaP c 7 66.99 f 7.06* 53.35 ?r 5.47* 120.09 + 23.62 
Rl.Pl-ApoaZF#6 c 6 67.71 + 10.68* 57.61 + 3.71* 119.11 rt 26.07 
Rl.Pi-Apoa2” BIG 4 89.07 f 13.40** 73.67 rt 3.73** 97.71 r 40.43 
Results represent mean + S.D. 
* Values in Rl.Pl-Apoa2’ and Rl.Pl-Apoa2%6 mice were significantly lower than those in SAM-R/l mice (P < 0.001, Student’s r-test). 
**Values in Rl.Pl-ApoaZs” were significantly higher than those in Rl.Pl-ApoaT mice (P < 0.01, Student’s t-test). 
strains. Thus the level and size of HDL were determined 
by a molecular type of apoA-II. 
Age-associated severe amyloid deposition is the most 
characteristic pathologic finding in the short-lived and 
senescence-accelerated mouse strain SAM-P/l. Al- 
though we found that the phenot~e of accelerated am- 
yloid deposition co-segregated with the type C apoA-II 
gene locus [3,5], we had no definite data concerning the 
interaction between accelerated senescence and acceler- 
ated amyloid deposition in the SAM-P/l strain. Using 
the congenic strains carrying only a small portion of 
chromosome 1 surrounding the apoA-II gene, from the 
SAM-P/l strain on the genetic background of the SAM- 
R/l strain with normal aging process, will shed light on 
this interesting and important question. This approach 
will avoid inestimable effects by unknown genes dis- 
persed over the mouse genome. 
The SAM-P/l strain has a characteristic lipoprotein 
metabolism. The presence of type C apoA-II reduced 
the plasma level and particle size of HDL, determined 
by using apoA-II congenic strains. Ongoing investiga- 
tions on age-associated changes in lipoprotein metabo- 
lism in the congenic strain will shed light on the role of 
a characteristic lipoprotein metabolism in SAM-P/l in 
the development of senile amyloidosis. 
The functions and biogenesis of HDL have yet to be 
entirely elucidated. Epidemiological data suggest an in- 
verse correlation between HDL cholesterol evels and 
risk of coronary artery disease [13]. In mice, genetic 
studies revealed that decreases in HDL cholesterol ev- 
els in response to a high fat diet co-segregated with 
susceptibility to diet-induced atherosclerosis [14]. Al- 
though apoA-II is the second most abundant protein 
constituent of human and mouse HDL, the physiologi- 
cal role of apoA-II in HDL metabolism has not been 
clearly defined. Recent studies revealed that structural 
differences between mouse type A and type B apoA-II 
affects the apoA-II translation efficiency and the size of 
the HDL is altered [l&16]. The Rl*Pl-ApoaT strain 
could be a excellent model to study the function of 
apoA-II. 
Human apoA-II amyloid protein or apoA-II vari- 
210 
ants, except for A5~1 restriction enzyme pol~orphism 
in the apoA-II gene reported by Scott et al. [17] have not 
been found. Our finding will aid in the search for apoA- 
II variants affecting amyloidosis and lipid metabolism 
in humans. 
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